05/14/2026
Great news! On May 7th, the first patient in the world received a drug in their vagus nerve. The patient was a 22 yr old GAN patient, named Hannah, the inspiration of HHF! Sheβs doing wonderfully and will be discharged from the hospital tomorrow. This intervention aims to regenerate peripheral nerves involved in involuntary functions of the autonomic nervous system. It will likely be several months before we see any benefit.
HHF is working to get a dose escalation study off the ground for the first gene therapy it funded the development of that targets the motor neurons in the central nervous system (CNS). Additionally, we aim to begin injecting milder GAN patients this year. It has been a long haul, but we hope to have all rights back to the CNS program any day now.
Thank you all who have helped HHF on this mission since 2008!
(First photo below is of Hannah and neurosurgeon, Dr. Angela Price, the MD that performed this procedure.)